Immunai
Dr. Matthew Hellmann received a BA from the University of Pennsylvania, MD from Johns Hopkins University, completed residency training in Internal Medicine at the Massachusetts General Hospital, and medical oncology fellowship training atMemorial Sloan Kettering Cancer Center.
Dr.Hellmann is now an Associate Attending at Memorial Sloan Kettering, specializing in the care of patients with lung cancers. His research focuses on identifying the predictors of response to immunotherapies and developing new ways to harness the body’s immune system to fight cancer.
This person is not in the org chart
This person is not in any offices
Immunai
2 followers
Immunai is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.